Advanced Pain Relief (formerly known as Fem Ease™)


An effective solution for pain and inflammation

  • Effective muscle pain formula
  • Eases lower back pain and reduces symptoms of headaches
  • Relieves exercise-related muscle tightness
  • Relieves menstrual pain
  • Clinically supported ingredients and doses
Gluten Free

$35.95 or subscribe and get 15% off

In stock

Choose a subscription plan:

Buy & Checkout
If you purchase this product you will earn 3595

Advanced Pain Relief was designed as a combination of well-studied and natural ingredients to target the causes of pain: namely, muscle tightness and inflammation. L-Carnitine, ginger, and curcumin have all been shown to help reduce muscle cramping, pain and inflammation, including menstrual-related cramping and headaches.

It can also support muscle recovery after intense activity. Ginger has even been shown to be as effective as over-the-counter anti-inflammatories, known as NSAIDs. Magnesium and California poppy provide additional mood support and relaxation effects, which are particularly important for those suffering with chronic pain.

Whether you are an athlete who experiences frequent muscle tension or someone who experiences chronic muscle pain and discomfort, Advanced Pain Relief is useful for relaxing tight neck and back muscles and relieving general inflammation.

AOR Advantage

Advanced Pain Relief recognizes the multifactorial nature of pain, addressing cramping, inflammation, and even the perception of pain, to provide a well-rounded option for relief.





Advanced Pain Relief helps relieve pain associated with menstruation and is traditionally used in herbal medicine as an analgesic and sedative, and in Ayurveda to relieve pain and inflammation.


AOR™ guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, peanuts, sulphites, dairy, eggs or any animal byproduct.

Adult Dosage

Take three capsules one to three times daily with food. For postexercise muscle recovery: Take two to four hours before exercise, or as directed by a qualified health care practitioner. For menstrual pain relief: Take for two days prior to menstruation and three days after, or as directed by a qualified health care practitioner. For general analgesic relief: Take the recommended dose, or as directed by a qualified health care practitioner


Consult a health care practitioner prior to use if you are breastfeeding, taking antiplatelet medication or blood thinners, if you have gallstones, a bile duct obstruction, stomach ulcers, excess stomach acid, liver or kidney disease, or a seizure disorder. Consult a health care practitioner if symptoms persist or worsen. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. Consumption with alcohol, other medications or natural health products with sedative and/or analgesic properties is not recommended.

Do not use if you are pregnant.This product contains soy derived ingredients, do not use if you have such allergies.

Main Applications
  • Supports a healthy menstrual cycle

The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide or replace medical advice to individuals from a qualified health care professional. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes.

Serving Size: Three Capsules
Magnesium (bisglycinate)
100 mg
Optimized Curcumin* (Curcuma longa root)
40 mg
California Poppy extract (Eschscholzia californica)
20 mg
L-Carnitine (tartrate)
680 mg
Ginger extract (Zingiber officinale)
100 mg

* LONGVIDA® is a registered trademark of Verdure Sciences Inc. International patent pending.

Non-medicinal Ingredients: Stearic acid, ascorbyl palmitate, soy lecithin, maltodextrin, gum arabic, microcrystalline cellulose and silicon dioxide.

Capsule: hypromellose.

Abass, M. 2012. Evaluation of Serum Magnesium , Hemoglobin and Body Mass Index in Dysmenorrheic Women in Tikrit Ciy/Iraq, Tikrit. Journal of Pure Science; 17(4): 59-62.

Allais G, Bussone G, De Lorenzo C, Mana O, Benedetto C. Advanced strategies of short-term prophylaxis in menstrual migraine: state of the art and prospects. Neurol Sci. 2005 May;26 Suppl 2:s125-9.

Berna, C., Leknes, S., Holmes, E., Edwards, R., Goodwin, G., & Tracey, I. 2010. Induction of Depressed Mood Disrupts Emotion Regulation Neurocircuitry and Enhances Pain Unpleasantness. Biological Psychiatry; 67(11): 1083-90.

Bettendorf B, Shay S, Tu F. Dysmenorrhea: contemporary perspectives. Obstet Gynecol Surv. 2008 Sep;63(9):597-603.

Chan, W. & Hill, J. 1978. Determination of Menstrual Prostaglandin Levels in Non-dysmenorrheic and Dysmenorrheic Subjects. Prostaglandins; 15(2): 365-375.

Dawood, M. 1986. Current Concepts in the Etiology and Treatment of Primary Dysmenorrhea. Acta Obstet Gynecol Scand Suppl; 138: 7–10.

Facchinetti, F., Borella, P., Sances, G., Fioroni, L., Nappi, R. , & Genazzani, A. 1991. Oral Magnesium Successfully Relieves Premenstrual Mood Changes. Obstetrics & Gynecology; 78(2): 177.

Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G (1991). Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 31:298–301

Fontana-Klaiber H, Hogg B. Therapeutic effects of magnesium in dysmenorrhea. Schweiz Rundsch Med Prax. 1990 Apr 17;79(16):491-4.

Gafner, S., Dietz, B., McPhail, K., Scott, I., Glinski, J., Russell, F., McCollom, M., Budzinski, J., Foster, B., Bergeron, C., Rhyu, M., & Bolton, J. 2006. Alkaloids from Eschscholzia californica and Their Capacity to Inhibit Binding of [3H]8-Hydroxy-2-(di-N-propylamino)tetralin to 5-HT1A Receptors in vitro. J Nat rod.; 69(3): 432-435.

Ghayur, M. & Gilani, A. 2007. Inhibitory Activity of Ginger Rhizome on Airway and Uterine Smooth Muscle Preparations. European Food Research and Technology; 224(4): 477-481.

Gollenberg, A., Hediger, M., Mumford, S., Whitcomb, B., Hovey, K., Wactawski-Wende, J., & Schisterman, E. 2010. Perceived Stress and Severity of Perimenstrual Symptoms: The BioCycle Study. Journal of Women’s Health; 19(5): 959-967.

Gulcin I. 2006. Antioxidant and Antiradical Activities of L-Carnitine. Life Science; 78: 803-811.

Jenabi, E. 2013. The effect of Ginger for Relieving of Primary Dysmenorrhoea. J Pak Med Assoc.; 63(1): 8-10.

Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014;36(1):104-13.

Kiuchi, F., Iwakami, S., Shibuya, M., Hanaoka, F., & Sankawa, U. 1992. Inhibition of Prostaglandin and Leukotriene Biosynthesis by Gingerols and Diarlherptanoids, Chem Pharm Bull.; 40(2): 387-391.

Ko, Y. , Hong, S., & Pedersen, P. 1999. Chemical Mechanism of ATP Synthase. Magnesium Plays a Pivotal Role in Formation of the Transition State Where ATP is Synthesized from ADP and Inorganic Phosphate. Journal of Biological Chemistry; 274(41): 28853-28856.

Kumar A, Purwar B, Shrivastava A, Pandey S. Effects of curcumin on the intestinal motility of albino rats. Indian J Physiol Pharmacol. 2010 Jul-Sep;54(3):284-8.

Ozgoli, G., Marjan, G., & Fariborz M. 2009. Comparison of Effects of Ginger, Mefenamic Acid, and Ibuprofen on Pain in Women with Primary Dysmenorrhea. The Journal of Alternative and Complementary Medicine; 15(2): 129-132.

Pharmacopoeia of the People’s Republic of China, 2005, Part I, Volume I, page 121.

RaO, S., & Vijyasree, M. 2011. Oxidative Stress and Antioxidant Status in Primary Dysmenorrhea. Journal of Clinical and Diagnostic Research; 5: 509-511.

Rahnama, P., Montazeri, A., Huseini, H., Kianbakht, S. & Naseri, M. 2012. Effect of Zingiber officinale R. Rhizomes (Ginger) on Pain Relief in Primary Dysmenorrhea: A Placebo Randomized Trial. BMC Complementary and Alternative Medicine; 12:92.

Rupa Vani K, Veena KS, Subitha L, Hemanth Kumar VR, Bupathy A. Menstrual abnormalities in school going girls – are they related to dietary and exercise pattern? J Clin Diagn Res. 2013 Nov;7(11):2537-40.

Sakurauchi, Y., Matsumoto, Y., Shinzato, T., Takai, I., Nakamura, Y., Sato, M., & Maeda, K. 1998. Effects of L-Carnitine Supplementation on Muscular Symptoms in Hemodialyzed Patients. American Journal of Kidney Diseases; 32(2): 258-264.

Spiering, B., Kraemer, W., Vingren, J., Hatfield D., Fragala M., Ho J., Maresh C., Anderson J., & Volek, J. 2007. Responses of Criterion Variables to Different Supplemental Doses of L-Carnitine L-Tartrate. The Journal of Strength & Conditioning Research; 21(1): 259-264.

Stults-Kolehmainen, M., & Bartholomew, J. 2012. Psychological Stress Impairs Short-Term Muscular Recovery from Resistance Exercise. Medicine & Science in Sports & Exercise; 44(11): 2220-2227.

Wall, B., Stephens, F., Constantin-Teodosiu, D., Marimuthu, K., Macdonald, A. & Greenhaff, P. 2011.

Yanagida, T., Arata, T., & Oosawa, F. 1985. Sliding distance of actin filament induced by a myosin crossbridge during one ATP hydrolysis cycle. Nature; 316 (6026):366-369.

Please select a start rating
{{ | date:'medium'}}
Comment pending for approval
{{ | date:'medium'}}
Comment pending for approval
{{ | date:'medium'}}
Comment pending for approval